ArticleOrphanet journal of rare diseases2022

Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.

George A Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.